Azithromycin inhibits nontypeable Haemophilus influenzae-induced MUC5AC expression and secretion via inhibition of activator protein-1 in human airway epithelial cells.
暂无分享,去创建一个
Yasuaki Yamada | S. Kamihira | K. Yanagihara | Y. Morinaga | S. Kohno | Shigeki Nakamura | Koichi Yamada | Nobuko Araki
[1] Yasuaki Yamada,et al. Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. , 2009, Pulmonary pharmacology & therapeutics.
[2] K. Yanagihara,et al. Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin. , 2008, The Journal of antimicrobial chemotherapy.
[3] Kensei Komatsu,et al. Glucocorticoids inhibit nontypeable Haemophilus influenzae-induced MUC5AC mucin expression via MAPK phosphatase-1-dependent inhibition of p38 MAPK. , 2008, Biochemical and biophysical research communications.
[4] P. Hutchinson,et al. Cytotoxic T lymphocyte and natural killer cell responses to non‐typeable Haemophilus influenzae , 2008, Clinical and experimental immunology.
[5] R. Wu,et al. Regulation of airway mucin gene expression. , 2008, Annual review of physiology.
[6] Jian-Dong Li,et al. Synergistic induction of MUC5AC mucin by nontypeable Haemophilus influenzae and Streptococcus pneumoniae. , 2008, Biochemical and biophysical research communications.
[7] Ke Wang,et al. Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF‐κB , 2008, Respirology.
[8] S. Kohno,et al. Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells , 2007, Clinical and experimental immunology.
[9] B. Assael,et al. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. , 2006, Biochemical and biophysical research communications.
[10] H. Kubo,et al. Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells , 2006, Respiratory Physiology & Neurobiology.
[11] A. Torres,et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. , 2005, Archives of internal medicine.
[12] Jian-Dong Li,et al. Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKβ- IκBα-NF-κB signaling pathways , 2004 .
[13] Y. Hirakata,et al. Azithromycin Inhibits MUC5AC Production Induced by the Pseudomonas aeruginosa Autoinducer N-(3-Oxododecanoyl) Homoserine Lactone in NCI-H292 Cells , 2004, Antimicrobial Agents and Chemotherapy.
[14] Jian-Dong Li,et al. Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways. , 2004, Biochemical and biophysical research communications.
[15] M. Rosenthal,et al. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial , 2002, The Lancet.
[16] S. Bell,et al. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial , 2002, Thorax.
[17] M. Knowles,et al. Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.
[18] Jiahuai Han,et al. Novel Cytoplasmic Proteins of Nontypeable Haemophilus influenzae Up-regulate Human MUC5AC Mucin Transcription via a Positive p38 Mitogen-activated Protein Kinase Pathway and a Negative Phosphoinositide 3-Kinase-Akt Pathway* , 2002, The Journal of Biological Chemistry.
[19] C. Basbaum,et al. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells , 2002, Nature Medicine.
[20] H. Kaida,et al. [Two cases successfully treated with long-term administration of low-dosage azithromycin]. , 2001, The Japanese journal of antibiotics.
[21] E. Mason,et al. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. , 2001, American journal of respiratory and critical care medicine.
[22] M. Yamaya,et al. Erythromycin and common cold in COPD. , 2001, Chest.
[23] A. Smith,et al. Acid phosphatase activity as a measure of Haemophilus influenzae adherence to mucin. , 1999, Journal of microbiological methods.
[24] A. Cripps,et al. Nontypeable Haemophilus influenzae: Pathogenesis and Prevention , 1998, Microbiology and Molecular Biology Reviews.
[25] S. Kudoh,et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. , 1998, American journal of respiratory and critical care medicine.
[26] Jian-Dong Li,et al. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. , 1998, Biochimica et biophysica acta.
[27] L. Duffy,et al. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first two years of life. , 1996, Acta oto-laryngologica. Supplementum.
[28] M. Fukakusa,et al. [Study on azithromycin in treatment of diffuse panbronchiolitis]. , 1995, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.